Michael Chastain

3.7k citations

20 papers · 1.8k indexed · 1 hit paper · h-index 16

Impact in

Virology top 5%
- HIV Research and Treatment
Immunology top 5%
- Immunotherapy and Immune Responses

Papers in ⓘ

Virology 5
- HIV Research and Treatment 5
Biotechnology 4
- Cancer Research and Treatments 3

Co-authors: Ignacio Tinoco (4 shared papers)Jacqueline R. Wyatt (1 shared paper)Joseph D. Puglisi (1 shared paper)Howard L. Kaufman (2 shared papers)Mohammed Milhem (2 shared papers)Kevin Gorski (2 shared papers)Jeffrey Chou (2 shared papers)Igor Puzanov (2 shared papers)
Journals: Journal of Clinical Oncology (3 papers)Vaccine (3 papers)Biochemistry (2 papers)Journal of Virology (2 papers)Molecular Therapy (1 paper)
Partner nations: United States Japan

In The Last Decade

Michael Chastain

20 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma 2016 · 435 citations

Peers

Countries citing papers authored by Michael Chastain

Since Specialization

Citations

This map shows the geographic impact of Michael Chastain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Chastain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Chastain more than expected).

Fields of papers citing papers by Michael Chastain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Chastain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Chastain. The network helps show where Michael Chastain may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Chastain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Chastain Line = papers co-authored together Michael Chastain links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Talimogene Laherparepvec in Combination With Ipilimumab in Previously Untreated, Unresectable Stage IIIB-IV Melanoma Journal of Clinical Oncology ·Igor Puzanov, Mohammed Milhem, David R. Minor, Omid Hamid, Li Ai, Lisa Chen, Michael Chastain, Kevin Gorski, Abraham Anderson, Jeffrey Chou, Howard L. Kaufman, Robert H.I. Andtbacka Hit paper breakdown →	2016	435
2	Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys Vaccine ·Fan Jiang, Xiaoping Liang, Melanie Horton, Helen C. Perry, Michael Citron, Gwen Heidecker, Tong‐Ming Fu, Joseph G. Joyce, Craig T. Przysiecki, Paul M. Keller, Victor M. Garsky, Roxana Ionescu, Yvette Rippeon, Li Shi, Michael Chastain, Jon H. Condra, Mary-Ellen Davies, Jason J. Z. Liao, Emilio A. Emini, John W. Shiver	2004	275
3	Synthesis and purification of large amounts of RNA oligonucleotides. PubMed ·Jacqueline R. Wyatt, Michael Chastain, Joseph D. Puglisi	1991	169
4	Enhancement of DNA vaccine potency using conventional aluminum adjuvants Vaccine ·Jeffrey B. Ulmer, Corrille M. DeWitt, Michael Chastain, Arthur Friedman, John Donnelly, W.L. McClements, Michael J. Caulfield, Kathryn E. Bohannon, David B. Volkin, Robert K. Evans	1999	113
5	Structural Elements in RNA Progress in nucleic acid research and molecular biology ·Michael Chastain, Ignacio Tinoco	1991	111
6	A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors BMC Medical Genomics ·Andrey Loboda, Michael Nebozhyn, Rich A. Klinghoffer, Jason P. Frazier, Michael Chastain, William T. Arthur, Brian S. Roberts, Theresa Zhang, Mélissa Chénard, Brian B. Haines, Jannik N. Andersen, Kumiko Nagashima, Cloud P. Paweletz, Bethany Lynch, Igor Feldman, Hongyue Dai, Pearl S. Huang, James Watters	2010	107
7	An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions Proceedings of the National Academy of Sciences ·Joseph G. Joyce, Isaac J. Krauss, Hong Chang Song, David Opalka, Karen M. Grimm, Deborah D. Nahas, Mark T. Esser, Renee Hrin, Meizhen Feng, Vadim Dudkin, Michael Chastain, John W. Shiver, Samuel J. Danishefsky	2008	104
8	Fully Synthetic Carbohydrate HIV Antigens Designed on the Logic of the 2G12 Antibody Journal of the American Chemical Society ·Isaac J. Krauss, Joseph G. Joyce, Adam C. Finnefrock, Hong Chang Song, Vadim Dudkin, Xudong Geng, J. David Warren, Michael Chastain, John W. Shiver, Samuel J. Danishefsky	2007	91
9	Heterologous Human Immunodeficiency Virus Type 1 Priming-Boosting Immunization Strategies Involving Replication-Defective Adenovirus and Poxvirus Vaccine Vectors Journal of Virology ·Danilo R. Casimiro, Andrew J. Bett, Tong‐Ming Fu, Mary-Ellen Davies, Aimin Tang, Keith Wilson, Minchun Chen, Romnie Long, Troy W. McKelvey, Michael Chastain, Sanjay Gurunathan, Jim Tartaglia, Emilio A. Emini, John W. Shiver	2004	81
10	Primary analysis of a phase 1b multicenter trial to evaluate safety and efficacy of talimogene laherparepvec (T-VEC) and ipilimumab (ipi) in previously untreated, unresected stage IIIB-IV melanoma. Journal of Clinical Oncology ·Igor Puzanov, Mohammed Milhem, Robert Hans Ingemar Andtbacka, David R. Minor, Omid Hamid, Ai Li, Michael Chastain, Kevin Gorski, Abraham Anderson, Ari M. Vanderwalde, Jeffrey Chou, Howard L. Kaufman	2014	69
11	A base-triple structural domain in RNA Biochemistry ·Michael Chastain, Ignacio Tinoco	1992	37
12	T-cell response to adenovirus hexon and DNA-binding protein in mice Gene Therapy ·Troy W. McKelvey, A Tang, Andrew J. Bett, Danilo R. Casimiro, Michael Chastain	2004	35
13	Vaccine-Induced Immune Responses in Rodents and Nonhuman Primates by Use of a Humanized Human Immunodeficiency Virus Type 1 pol Gene Journal of Virology ·Danilo R. Casimiro, Aimin Tang, Helen C. Perry, Romnie Long, Minchun Chen, Gwendolyn J. Heidecker, Mary-Ellen Davies, Daniel C. Freed, Natasha Persaud, Sheri Dubey, Jeffrey G. Smith, Diane V. Havlir, Douglas D. Richman, Michael Chastain, Adam Simon, Tong‐Ming Fu, Emilio A. Emini, John W. Shiver	2002	34
14	Antigen levels and antibody titers after DNA vaccination Journal of Pharmaceutical Sciences ·Michael Chastain, Adam Simon, Keith A. Soper, Daniel Holder, Donna L. Montgomery, Sangeetha L. Sagar, Danilo R. Casimiro, C. Russell Middaugh	2001	33
15	Nucleoside triples from the group I intron Biochemistry ·Michael Chastain, Ignacio Tinoco	1993	22
16	Poly(rA) ioinos poly(rG) poly(rC) to form a tripie helix Nucleic Acids Research ·Michael Chastain, Ignacio Tinoco	1992	18
17	Enhanced in vivo transgene expression and immunogenicity from plasmid vectors following electrostimulation in rodents and primates Vaccine ·Adam Simon, Danilo R. Casimiro, Adam C. Finnefrock, Mary-Ellen Davies, Aimin Tang, Minchun Chen, Michael Chastain, Gary S. Kath, Ling Chen, John W. Shiver	2008	15
18	Phase 2, multicenter, randomized, open-label trial assessing efficacy and safety of talimogene laherparepvec (T-VEC) neoadjuvant treatment (tx) plus surgery vs surgery for resectable stage IIIB/C and IVM1a melanoma (MEL). Journal of Clinical Oncology ·Robert Hans Ingemar Andtbacka, Michael Chastain, Li Ai, Mark Shilkrut, Merrick I. Ross	2015	13
19	Vaccination of Mice with Replication-Defective Human Immunodeficiency Virus Induces Cellular and Humoral Immunity and Protects against Vaccinia Virus-gag Challenge Molecular Therapy ·Christopher Baliga, Marc van Maanen, Michael Chastain, Richard E. Sutton	2006	5
20	Abstract B13: A phase 2, randomized, open-label trial assessing efficacy and safety of talimogene laherparepvec (T-VEC) neoadjuvant treatment (tx) plus surgery vs. surgery for resectable stage IIIB-IVM1a melanoma Cancer Research ·Robert H.I. Andtbacka, M. Shabooti, Ai Li, Michael Chastain, Mark Shilkrut	2015	2

About Michael Chastain

Michael Chastain is a scholar working on Virology, Biotechnology, Genetics, Immunology and Oncology, having authored 20 papers that have together received 1.8k indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), HIV Research and Treatment (5 papers), CAR-T cell therapy research (5 papers), Cancer Research and Treatments (3 papers), RNA and protein synthesis mechanisms (3 papers), Immunotherapy and Immune Responses (3 papers), RNA Interference and Gene Delivery (3 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Virology (184 citations), Immunology (557 citations), Oncology (518 citations), Genetics (404 citations) and Molecular Biology (934 citations). Michael Chastain has collaborated with scholars based in United States and Japan. Frequent co-authors include Ignacio Tinoco, Jacqueline R. Wyatt, Joseph D. Puglisi, Howard L. Kaufman, Mohammed Milhem, Kevin Gorski, Jeffrey Chou, Igor Puzanov, Omid Hamid and Abraham Anderson. Their work appears in journals such as Journal of Clinical Oncology, Vaccine, Biochemistry, Journal of Virology and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact